1. IDENTIFICATION & BASIC DESCRIPTION |
Cohort name
|
|
Mexico City Prospective Study
|
Country
|
|
|
Please provide any other information on the cohort location/s if needed
|
|
Mexico City
|
Name
|
|
Roberto Tapia-Conyer
|
Institution
|
|
National Autonomous University of Mexico
|
Email
|
|
mcps-access@ndph.ox.ac.uk
|
Name
|
|
Jonathan Emberson
|
Institution
|
|
University of Oxford
|
Email
|
|
mcps-access@ndph.ox.ac.uk
|
Website
|
|
- https://www.ctsu.ox.ac.uk/research/prospective-blood-based-study-of-150-000-individuals-in-mexico
|
Name of committee
|
|
Mexican Ministry of Health; Mexican National Council for Science and Technology; University of Oxford
|
Upload files
|
|
|
Contact Principal Investigator (name)
|
|
Jonathan Emberson
|
Data access policy (briefly describe)
|
|
We welcome requests from researchers who wish to access data from the Mexico City Prospective Study. If you are interested in obtaining data from the study for research purposes, or in collaborating with us on a specific research proposal, please visit our study website [https://www.ctsu. ox.ac.uk/research/prospective-blood-based-study-of-150- 000-individuals-in-mexico] where you can download our Data and Sample Access Policy in either English or Spanish.
|
Is this cohort part of a consortium? (name consortium)
|
|
No
|
Main aim of cohort, please briefly describe the main objectives of the cohort
|
|
To study the major social, lifestyle, physical, metabolic and genetic causes of disease in Mexican adults
|
Study design (please select as many as appropriate)
|
|
|
Source population (please select as many as appropriate)
|
|
- General population: Regional
|
Comparators (please select as many as appropriate)
|
|
- Internal study population
|
Inclusion criteria
|
|
Age 35 years or older from two districts of Mexico City
|
Exclusion criteria
|
|
None
|
Enrollment
|
|
Completed
|
Age range at entry (main cohort)
|
|
Minimum |
Maximum |
Mean |
35 |
No upper age limit |
|
|
Men at enrollment
|
|
~50,000
|
Women at enrollment
|
|
~100,000
|
Children (<18 years) at enrollment
|
|
0
|
2. OUTCOME FOLLOW-UP |
Type of data for outcome follow-up (please select as many as appropriate)
|
|
|
First follow-up period (provide year)
|
|
1998
|
Last follow-up period (provide year)
|
|
2018
|
Number of follow-ups after baseline (provide number)
|
|
1
|
Participation at last follow-up (if known)
|
|
7
|
Comments
|
|
Between 2015-2019 a resurvey of 10,000 survivors was completed.
|
3. OCCUPATIONAL EXPOSURES |
Source of exposure data collected (please select as many as appropriate)
|
|
- Questionnaire, Personal (Self-reporting or interview)
|
Occupational history/time frame
|
|
Current, at enrollment
|
Occupational coding performed
|
|
No
|
Types of exposure measurements
|
|
|
Specify: Other
|
|
Questionnaire data, physical measurements and blood biomarkers
|
Methods for exposure assessment (please select as many as appropriate)
|
|
- Measurements (external sampling, biomarkers)
- Self-report
|
Main categories
|
|
|
Main categories | Other | Specify: Other
|
|
None
|
4. OUTCOMES EVALUATED |
Baseline - type of outcome data collected (select more than one if applicable)
|
|
- Biomarker (specify)
- Questionnaire, individual (self-recording or interview)
|
Specify: Biomarker
|
|
A range of blood biomarkers
|
Follow-up - type of outcome data collected (select more than one if applicable)
|
|
|
Outcome type (please select as many as appropriate)
|
|
|
Diagnostic groups based on ICD10
|
|
|
Other (specify)
|
|
Death certificates are coded according to ICD-10
|
5. BIOLOGICAL SAMPLES & ANALYSIS |
Biological samples collected
|
|
|
Biological processing
|
|
|
Genetic and other lab analyses
|
|
- Biomarkers (specify)
- Genomics / GWAS
- Genomics / Other genetics (specify)
- Metabolomics
|
Specify: Biomarkers
|
|
A range of blood biomarkers have been measured.
|
Specify: Other genetics
|
|
Exome sequence data
|
6. Other Information |
|
|
- Alcohol
- Anthropometry
- Demographics
- Diet
- Education
- Medical history
- Physical exercise
- Socioeconomic status
- Smoking
|